181 related articles for article (PubMed ID: 35576590)
1. Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018.
Rosenblum HG; Lewis RM; Gargano JW; Querec TD; Unger ER; Markowitz LE
Ann Intern Med; 2022 Jul; 175(7):918-926. PubMed ID: 35576590
[TBL] [Abstract][Full Text] [Related]
2. Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018.
Rosenblum HG; Lewis RM; Gargano JW; Querec TD; Unger ER; Markowitz LE
MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):415-420. PubMed ID: 33764964
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of HPV After Introduction of the Vaccination Program in the United States.
Markowitz LE; Liu G; Hariri S; Steinau M; Dunne EF; Unger ER
Pediatrics; 2016 Mar; 137(3):e20151968. PubMed ID: 26908697
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014.
Oliver SE; Unger ER; Lewis R; McDaniel D; Gargano JW; Steinau M; Markowitz LE
J Infect Dis; 2017 Sep; 216(5):594-603. PubMed ID: 28931217
[TBL] [Abstract][Full Text] [Related]
5. Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey.
McClung NM; Lewis RM; Gargano JW; Querec T; Unger ER; Markowitz LE
J Adolesc Health; 2019 Dec; 65(6):715-722. PubMed ID: 31515134
[TBL] [Abstract][Full Text] [Related]
6. Genital Human Papillomavirus Prevalence Over the Lifespan Among Females and Males in a National Cross-Sectional Survey, United States, 2013-2016.
Lewis RM; Gargano JW; Unger ER; Querec TD; Markowitz LE
Sex Transm Dis; 2021 Nov; 48(11):855-863. PubMed ID: 34009919
[TBL] [Abstract][Full Text] [Related]
7. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2017 Jan; 17(1):68-77. PubMed ID: 27282422
[TBL] [Abstract][Full Text] [Related]
8. The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model.
Chesson HW; Markowitz LE; Hariri S; Ekwueme DU; Saraiya M
Hum Vaccin Immunother; 2016 Jun; 12(6):1363-72. PubMed ID: 26890978
[TBL] [Abstract][Full Text] [Related]
9. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study.
Tabrizi SN; Brotherton JM; Kaldor JM; Skinner SR; Liu B; Bateson D; McNamee K; Garefalakis M; Phillips S; Cummins E; Malloy M; Garland SM
Lancet Infect Dis; 2014 Oct; 14(10):958-66. PubMed ID: 25107680
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus (HPV) Vaccine Effectiveness and Potential Herd Immunity for Reducing Oncogenic Oropharyngeal HPV-16 Prevalence in the United Kingdom: A Cross-sectional Study.
Mehanna H; Bryant TS; Babrah J; Louie K; Bryant JL; Spruce RJ; Batis N; Olaleye O; Jones J; Struijk L; Molijn A; Vorsters A; Rosillon D; Taylor S; D'Souza G
Clin Infect Dis; 2019 Sep; 69(8):1296-1302. PubMed ID: 30590469
[TBL] [Abstract][Full Text] [Related]
11. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.
Markowitz LE; Hariri S; Lin C; Dunne EF; Steinau M; McQuillan G; Unger ER
J Infect Dis; 2013 Aug; 208(3):385-93. PubMed ID: 23785124
[TBL] [Abstract][Full Text] [Related]
12. The impact of over ten years of HPV vaccination in England: Surveillance of type-specific HPV in young sexually active females.
Checchi M; Mesher D; Panwar K; Anderson A; Beddows S; Soldan K
Vaccine; 2023 Oct; 41(45):6734-6744. PubMed ID: 37821315
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017.
Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Regan DG; Hocking JS; Garland SM; Cornall AM; Atchison S; Bradshaw CS; McNulty A; Owen L; Marshall L; Russell DB; Kaldor JM; Chen MY
Vaccine; 2019 Oct; 37(46):6907-6914. PubMed ID: 31562001
[TBL] [Abstract][Full Text] [Related]
14. Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis.
Closson K; Karim ME; Sadarangani M; Naus M; Ogilvie GS; Donken R
Vaccine; 2020 Dec; 38(52):8396-8404. PubMed ID: 33239227
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study.
Chow EP; Danielewski JA; Fehler G; Tabrizi SN; Law MG; Bradshaw CS; Garland SM; Chen MY; Fairley CK
Lancet Infect Dis; 2015 Nov; 15(11):1314-23. PubMed ID: 26201300
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Genital Human Papillomavirus Infection and Human Papillomavirus Vaccination Rates Among US Adult Men: National Health and Nutrition Examination Survey (NHANES) 2013-2014.
Han JJ; Beltran TH; Song JW; Klaric J; Choi YS
JAMA Oncol; 2017 Jun; 3(6):810-816. PubMed ID: 28114440
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Genital Human Papillomavirus in Males, United States, 2013-2014.
Gargano JW; Unger ER; Liu G; Steinau M; Meites E; Dunne E; Markowitz LE
J Infect Dis; 2017 Apr; 215(7):1070-1079. PubMed ID: 28170037
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Human Papillomavirus in Self-Collected Cervicovaginal Swabs in Young Women in the United States Between 2003 and 2012.
Tarney CM; Klaric J; Beltran T; Pagan M; Han J
Obstet Gynecol; 2016 Dec; 128(6):1241-1247. PubMed ID: 27824760
[TBL] [Abstract][Full Text] [Related]
19. High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018.
Stefanos R; Lewis RM; Querec TD; Gargano JW; Unger ER; Markowitz LE
Hum Vaccin Immunother; 2024 Dec; 20(1):2308378. PubMed ID: 38372273
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Oral Human Papillomavirus Infection: Impact of Sex, Race/Ethnicity, and Vaccination Status.
Berenson AB; Hirth JM; Chang M
Clin Infect Dis; 2022 Apr; 74(7):1230-1236. PubMed ID: 34218280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]